Atrial Fibrillation: all 3,957 studies
Page 39 of 40. Open to participants first (933), then studies with results posted, then the rest; newest registration first within each.
- Primary Anatomical Versus Primary Electrophysiological Approach in Circumferential Pulmonary Vein AblationStatus unknownNCT00556595Not applicable
- AVJ Ablation Followed by Resynchronization Therapy in Patients With CHF and AFTerminatedNCT00547794
- Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze ProcedureCompletedNCT00542659
- A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial FibrillationCompletedNCT00540787Phase 4
- Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial FibrillationTerminatedNCT00528307Not applicable
- Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion StudyCompletedNCT00526136Phase 2
- Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field SensingCompletedNCT00512915Phase 4
- Effects of Left Atrial Appendage OcclusionWithdrawnNCT00510900
- Omega 3 Fatty Acids and Atrial FibrillationWithdrawnNCT00508248Not applicable
- Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke IncidenceCompletedNCT00486915Not applicable
- Modeling Genotype and Other Factors to Enhance the Safety of Coumadin PrescribingStatus unknownNCT00484640Not applicable
- Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass GraftingCompletedNCT00484575Phase 1/2
- Follow-up Study of the RAI-Treated Hyperthyroid PatientsCompletedNCT00471458
- Efficacy and Safety Study on Agilis NxT Introducer in AF PatientsCompletedNCT00469638Not applicable
- Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial FibrillationCompletedNCT00468767Phase 3
- Atrial Fibrillation Ablation Device Comparison StudyWithdrawnNCT00466973Phase 4
- Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential HypertensionCompletedNCT00461903Phase 3
- Bi-Ventricular Pacing in Patients With Atrial Fibrillation and Heart Failure (BIFF-Study)Status unknownNCT00457834Phase 2
- Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF PatientsCompletedNCT00449410Phase 4
- Treatment of Atrial Fibrillation by Minimal Invasive SurgeryCompletedNCT00448656Phase 2
- Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial FibrillationCompletedNCT00448214Phase 2
- Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac SurgeryTerminatedNCT00442494Not applicable
- Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AFCompletedNCT00438113Phase 4
- Odiparcil QT Definitive StudyTerminatedNCT00437242Phase 1
- A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial FibrillationCompletedNCT00434694Not applicable
- Study of a New Anticoagulant Drug in Patients With Atrial FibrillationCompletedNCT00431782Phase 2
- Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.Status unknownNCT00429884
- SAFE Study - Septal Pacing for Atrial Fibrillation Suppression EvaluationCompletedNCT00419640Not applicable
- Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS ProcedureTerminatedNCT00415558Not applicable
- Investigation of Genetic Risk of Atrial FibrillationStatus unknownNCT00412438
- Studies of the Prevention of Atrial Fibrillation by ALAStatus unknownNCT00410839Phase 2
- Arrhythmia Prevention With an Alpha-Linolenic Enriched DietCompletedNCT00410020Phase 2
- Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.TerminatedNCT00408473Phase 4
- Evaluating the Relationship Between Fatty Acids and Heart DiseaseCompletedNCT00404872
- RAte Control Efficacy in Permanent Atrial FibrillationCompletedNCT00392613Not applicable
- Continuous Versus Episodic Amiodarone Treatment for the Prevention of Permanent Atrial FibrillationCompletedNCT00392431Not applicable
- High Intensity Focused Ultrasound (HIFU) Ablation System StudySuspendedNCT00392106Phase 3
- Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With PacemakersCompletedNCT00389792Phase 2
- PANORAMA Observational StudyCompletedNCT00382525
- Efficacy of Different Ablation Strategies for Controlling Atrial FibrillationCompletedNCT00379301Not applicable
- Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic GroupsCompletedNCT00377702
- GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation RecurrenceCompletedNCT00376272Phase 3
- KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial FibrillationWithdrawnNCT00369330Not applicable
- STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation TrialCompletedNCT00367757Not applicable
- Atrial Fibrillation and the Risk for Neurological ComplicationsStatus unknownNCT00357227
- The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With EnoxaparinStatus unknownNCT00354796
- Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)CompletedNCT00352560Phase 3
- The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)TerminatedNCT00343499Phase 4
- A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)CompletedNCT00340314Phase 4
- Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass SurgeryCompletedNCT00338715Phase 3
- A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"CompletedNCT00334464Not applicable
- After Discharge Management of Low Income Frail ElderlyCompletedNCT00328848Not applicable
- A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor BlockersCompletedNCT00321945
- Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of StatinsCompletedNCT00321802Phase 2
- A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial ArrhythmiasTerminatedNCT00321204
- Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter AblationStatus unknownNCT00315068
- RATe Control in Atrial FibrillationCompletedNCT00313157Phase 3
- ALA and Prostate CancerStatus unknownNCT00309439Phase 2
- Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial FibrillationTerminatedNCT00296166Not applicable
- Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic StenosisStatus unknownNCT00294775Phase 3
- Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial FibrillationCompletedNCT00293943Not applicable
- Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA ClassCompletedNCT00292539
- Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac SurgeryCompletedNCT00289367Phase 1
- Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)CompletedNCT00289042Phase 4
- Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)CompletedNCT00287209Phase 4
- SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular ConductionCompletedNCT00284830Not applicable
- Study of RSD1235 to Evaluate Safety in Patients With Atrial FibrillationCompletedNCT00281554Phase 3
- Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) StudyCompletedNCT00281073Phase 1/2
- Genomics and Postoperative Atrial FibrillationCompletedNCT00280163
- TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device DiagnosticsCompletedNCT00279981
- Radiofrequency Catheter Ablation for Chronic Atrial FibrillationCompletedNCT00272636Not applicable
- Clinical Investigation of the Medtronic Concerto™ DeviceCompletedNCT00268320Not applicable
- Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation (ReSync AF)CompletedNCT00268294Not applicable
- Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter RecurrenceCompletedNCT00267930Phase 2
- Study for Atrial Fibrillation Reduction (SAFARI)CompletedNCT00267137Not applicable
- RF Ablation of Atrial FibrillationCompletedNCT00265629Phase 1
- Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients: Efficacy at 3 MonthsCompletedNCT00259623Not applicable
- EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)CompletedNCT00259428Phase 3
- American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus RhythmCompletedNCT00259376Phase 3
- Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing TrialCompletedNCT00256152Phase 4
- Efficacy and Safety of AZD7009 in the Treatment of Atrial FibrillationCompletedNCT00255281Phase 2
- Amiodarone to Prevent Post-Operative ArrhythmiasCompletedNCT00251706Phase 3
- Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECGCompletedNCT00251121Not applicable
- The Genetic Basis of Atrial Fibrillation (AF)CompletedNCT00248326
- Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart SurgeryTerminatedNCT00248274
- Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial FibrillationCompletedNCT00247780Phase 4
- S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial FibrillationCompletedNCT00244426Phase 3
- Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial FibrillationTerminatedNCT00243802
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)TerminatedNCT00243178Phase 3
- Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For StrokeCompletedNCT00240643Phase 2
- Use of Radiofrequency Ablation to Eliminate Continuous Atrial Fibrillation in Patients Undergoing Mitral Valve SurgeryCompletedNCT00238706Not applicable
- Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/FlutterCompletedNCT00233441Phase 2/3
- Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttErCompletedNCT00232310Phase 2
- Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.CompletedNCT00232245Phase 4
- Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial ArrhythmiaCompletedNCT00232232Phase 4
- Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC CardioversionCompletedNCT00232219Phase 4
- Safety and Efficacy of CryoCor™ Cryoablation for PAFCompletedNCT00231296Not applicable
- Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent PacemakersStatus unknownNCT00225667Phase 3
- Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot StudyCompletedNCT00224757Not applicable
- Arrhythmia Restart Prevention and RatE STabilization in Atrial FibrillationStatus unknownNCT00224341Phase 4